Artur A. Serebrenik

Aug 29, 2023 | redjournal.org | Artur A. Serebrenik |Elizabeth Gore |Pranshu Mohindra |Stephen Brown

ABSTRACT: Radiotherapy is part of the standard treatment regimen for non-small cell lung cancer (NSCLC). While radiotherapy is an effective tool to manage NSCLC, it can be associated with significant dose-limiting toxicities. These toxicities can lead to treatment interruption or early termination, worsening clinical outcomes, in addition to reductions in patient quality of life.